Table 1.
Current subset (N = 292) | Parent trial (N = 612) | |
---|---|---|
Age | 76 (7.11) | 76 (7.4) |
Sex | ||
Female | 190 (65.1%) | 410 (67.0%) |
Male | 102 (34.9%) | 202 (33.0%) |
BMI (kg/m2) | 28 (4.72) | 28 (4.87) |
Missing | 1 (0.3%) | 3 (0.5%) |
CMV serostatus | ||
Negative | 130 (44.5%) | 287 (46.9%) |
Positive | 162 (55.5%) | 325 (53.1%) |
Frailty Index | 0.11 (0.0708) | 0.11 (0.0734) |
Missing | 0 (0%) | 2 (0.3%) |
Dose | ||
Standard | 145 (49.7%) | 316 (51.6%) |
High | 147 (50.3%) | 296 (48.4%) |
Site | ||
HSNRI | 184 (63.0%) | 356 (58.2%) |
UCHC | 108 (37.0%) | 256 (41.8%) |
Year | ||
2014/2015 | 58 (19.9%) | 106 (17.3%) |
2015/2016 | 79 (27.1%) | 175 (28.6%) |
2016/2017 | 83 (28.4%) | 174 (28.4%) |
2017/2018 | 72 (24.7%) | 157 (25.7%) |
Continuous data is summarized as the mean (standard deviation), whereas categorical data is the count (frequency)